Endocyte to present at 26th annual JPMorgan Healthcare Conference

Endocyte Inc.

RELATED INFO

January 4, 2007

Endocyte to present at 26th annual JPMorgan Healthcare Conference

WEST LAFAYETTE, Ind. - Endocyte Inc., a privately-held biotechnology company developing receptor-targeted therapeutics, announced Friday (Jan. 4) that it will be presenting at the 26th annual JPMorgan Healthcare Conference, which will take place at the Westin St. Francis Hotel in San Francisco.

Ron Ellis, Endocyte president and CEO, will present an overview of the company's development program and clinical pipeline at 4:30 p.m. Wednesday (Jan. 9) in the Elizabethan C/D Room.

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and involve significant risks and uncertainties that may cause results to differ materially from those set forth in the statements. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

Contact:
Vickey Buskirk, media relations, Endocyte Inc., (765) 463-7175 ext. 1117, vbuskirk@endocyte.com